Abbonarsi

Impact of salt substitute and stepwise reduction of salt supply on blood pressure in residents in senior residential facilities: Design and rationale of the DECIDE-Salt trial - 16/08/20

Doi : 10.1016/j.ahj.2020.05.013 
Aoming Jin, BS a, Kiang Liu, PhD b, Darwin R. Labarthe, MD, MPH, PhD b, Xiangxian Feng, PhD c, Ruijuan Zhang, MPH d, Hongxia Wang, MPH e, Qianku Qiao, MD f, Huijuan Li, PhD a, Jiayu Li, BS a, Pei Gao, PhD g, Hai Fang, PhD h, Peifen Duan, MPH c, Yuqi Wang, BS d, Hui Zhang, MPH e, Lae Cao, BD f, Bruce Neal, Ph i, j, Junshi Chen, PhD k, Yangfeng Wu, PhD a, g,
a Peking University Clinical Research Institute, Peking University First Hospital, Beijing, China 
b Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA 
c Changzhi Medical College, Shanxi, China 
d Xi'an Jiaotong University, Shaanxi, China 
e Hohhot Center for Disease Control and Prevention, Hohhot, Inner Mongolia, China 
f Yangcheng Ophthalmology Hospital, Shanxi, China 
g Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing, China 
h China Center for Health Development Studies, Peking University, Beijing, China 
i The George Institute for Global Health, Australia, Sydney, Australia 
j The University of Sydney, Sydney, Australia 
k National Center for Food Safety Risk Assessment, Beijing, China 

Reprint requests: Yangfeng Wu, PhD, Peking University Clinical Research Institute, Room 106, Bldg 6, No. 38 Xueyuan Rd, Haidian District, Beijing 100191, China.Peking University Clinical Research InstituteRoom 106, Bldg 6, No. 38 Xueyuan Rd, Haidian DistrictBeijing100191China

Abstract

Background

High sodium intake has been considered as the leading dietary risk factor for deaths and disability-adjusted life-years among older adults. High-quality randomized trials to evaluate the effects of practical sodium reduction strategies are needed.

Methods

The study is a cluster randomized trial with a 2 × 2 factorial design conducted in 48 senior residential facilities in northern China. These facilities are randomly assigned (1:1:1:1) to 1 of 4 groups: stepwise salt supply control (SSSC) in which 5%-10% of the study salt supply in the institutional kitchens will be reduced every 3 months, replacing normal salt with salt substitute (SS); SSSC only; SS only; or neither SSSC nor SS. The interventions last for 2 years with follow-up every 6 months. The primary outcome is the change in systolic blood pressure from baseline to 24 months. Secondary outcomes include the incidence of hyperkalemia, hyponatremia, cardiovascular events, and death.

Current status

The study has recruited and randomized 48 senior residential facilities with 1,606 participants. Mean age at baseline was 71 years, and 76% are male. Both types of salt intervention were initiated in the study facilities between January and April 2018.

Conclusion

The study is well placed to define the effects of 2 practical and scalable sodium reduction strategies for blood pressure reduction and will provide important new data about safety of these strategies among older adults in China.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2020  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 226

P. 198-205 - Agosto 2020 Ritorno al numero
Articolo precedente Articolo precedente
  • A multicenter trial of a shared DECision Support Intervention for Patients offered implantable Cardioverter-DEfibrillators: DECIDE-ICD rationale, design, Medicare changes, and pilot data
  • Bryan C. Wallace, Larry A. Allen, Christopher E. Knoepke, Russell E. Glasgow, Carmen L. Lewis, Diane L. Fairclough, Laura J. Helmkamp, Monica D. Fitzgerald, Wendy S. Tzou, Daniel B. Kramer, Paul D. Varosy, Sanjaya K. Gupta, John M. Mandrola, Scott C. Brancato, Pamela N. Peterson, Daniel D. Matlock
| Articolo seguente Articolo seguente
  • Transcatheter InterAtrial Shunt Device for the treatment of heart failure: Rationale and design of the pivotal randomized trial to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure II (REDUCE LAP-HF II)
  • Natalia Berry, Laura Mauri, Ted Feldman, Jan Komtebedde, Dirk J. van Veldhuisen, Scott D. Solomon, Joseph M. Massaro, Sanjiv J. Shah

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.